1808.4000 9.50 (0.53%)
NSE Aug 01, 2025 15:31 PM
Volume: 96,925
 

1808.40
0.53%
Prabhudas Lilladhar
Strong FY26 guidance with +15% revenue growth with 36% OPM. up 70% YoY). Eris has opted for inorganic route to diversify and scale up expect margins to scale up from the current level of 35% as revenue scales up from recent acquisitions, which are currently operating at sub-optimal profitability. The company has multiple growth levers such as broad-based...
Number of FII/FPI investors increased from 178 to 193 in Jun 2025 qtr.
More from Eris Lifesciences Ltd.
Recommended